• 9538 Citations
  • 46 h-Index
20042020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where ByoungChul Cho is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 10 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in advanced squamous cell carcinoma of the head and neck: Results from a phase i cohort

Cho, B. C., Daste, A., Ravaud, A., Salas, S., Isambert, N., McClay, E., Awada, A., Borel, C., Ojalvo, L. S., Helwig, C., Rolfe, P. A., Gulley, J. L. & Penel, N., 2020 Jul 7, In : Journal for ImmunoTherapy of Cancer. 8, 2, jitc-2020-000664.

Research output: Contribution to journalArticle

Open Access
  • Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF-β and PD-L1, in Second-Line Treatment of Patients With NSCLC: Results From an Expansion Cohort of a Phase 1 Trial

    Paz-Ares, L., Kim, T. M., Vicente, D., Felip, E., Lee, D. H., Lee, K. H., Lin, C. C., Flor, M. J., Di Nicola, M., Alvarez, R. M., Dussault, I., Helwig, C., Ojalvo, L. S., Gulley, J. L. & Cho, B. C., 2020 Jan 1, (Accepted/In press) In : Journal of Thoracic Oncology.

    Research output: Contribution to journalArticle

  • 1 Citation (Scopus)

    Design and Rationale for a Phase III, Randomized, Placebo-controlled Trial of Durvalumab With or Without Tremelimumab After Concurrent Chemoradiotherapy for Patients With Limited-stage Small-cell Lung Cancer: The ADRIATIC Study

    Senan, S., Okamoto, I., Lee, G. W., Chen, Y., Niho, S., Mak, G., Yao, W., Shire, N., Jiang, H. & Cho, B. C., 2020 Mar, In : Clinical Lung Cancer. 21, 2, p. e84-e88

    Research output: Contribution to journalArticle

    Open Access
  • Establishment and characterization of patient-derived xenografts as paraclinical models for head and neck cancer

    Kang, H. N., Kim, J. H., Park, A. Y., Choi, J. W., Lim, S. M., Kim, J., Shin, E. J., Hong, M. H., Pyo, K. H., Yun, M. R., Kim, D. H., Lee, H., Yoon, S. O., Kim, D. H., Park, Y. M., Byeon, H. K., Jung, I., Paik, S., Koh, Y. W., Cho, B. C. & 1 others, Kim, H. R., 2020 Apr 15, In : BMC cancer. 20, 1, 316.

    Research output: Contribution to journalArticle

    Open Access
  • Osimertinib in patients with epidermal growth factor receptor mutation-positive non-small-cell lung cancer and leptomeningeal metastases: The BLOOM study

    Yang, J. C. H., Kim, S. W., Kim, D. W., Lee, J. S., Cho, B. C., Ahn, J. S., Lee, D. H., Kim, T. M., Goldman, J. W., Natale, R. B., Brown, A. P., Collins, B., Chmielecki, J., Vishwanathan, K., Mendoza-Naranjo, A. & Ahn, M. J., 2020 Feb 20, In : Journal of Clinical Oncology. 38, 6, p. 538-547 10 p.

    Research output: Contribution to journalArticle

  • 9 Citations (Scopus)

    Press / Media

    Repotrectinib highly active in ROS1-positive lung cancer

    ByoungChul Cho

    19/6/619/6/7

    3 items of Media coverage

    Press/Media: Press / Media